CAH Share Price | Cardinal Health, Inc. Stock Analysis & Recommendation

Q: How big is Cardinal Health, Inc.?

As of Jun 18, Cardinal Health, Inc. has a market capitalization of 46,451.36 million, categorizing it as a Large Cap company.As of Jun 24, the company reported net sales of 222,286.00 million and a net profit of 1,559.00 million for the latest four quarters.As of Jun 24, the shareholder's funds were reported at -3,213.00 million, while total assets amounted to 45,121.00 million.

Q: What does Cardinal Health, Inc. do?

Overview:Cardinal Health, Inc. is a healthcare services and products company operating in the Retailing industry, with a market cap in the large-cap bracket.Financial Snapshot:- Net Sales: 54,878 Million (Quarterly Results - Mar 2025)- Net Profit: 508 Million (Quarterly Results - Mar 2025)- Market cap: USD 46,451.36 Million (Large Cap)Key Metrics:- P/E: 27.00- Dividend Yield: 0.00%- Debt Equity: -1.48- Return on Equity: -55.76%- Price to Book: -15.76Contact Details:- Address: 7000 Cardinal Pl, DUBLIN OH: 43017-1091- Tel: 1 614 7573033- Website: https://www.cardinalhealth.com/

Q: Who are in the management team of Cardinal Health, Inc.?

As of March 2022, the management team of Cardinal Health, Inc. includes the following individuals:- Mr. Gregory Kenny, who serves as the Independent Non-Executive Chairman of the Board.- Mr. Michael Kaufmann, who is the Chief Executive Officer and a Director.- Ms. Carrie Cox, who is an Independent Director.- Mr. Calvin Darden, who is also an Independent Director.- Mr. Bruce Downey, serving as an Independent Director.- Ms. Sheri Edison, who is another Independent Director.In summary, as of March 2022, Cardinal Health, Inc. has a diverse management team led by Mr. Michael Kaufmann as CEO, with Mr. Gregory Kenny as the Chairman and several Independent Directors contributing to the board.

Q: Is Cardinal Health, Inc. overvalued or undervalued?

As of 5 May 2022, Cardinal Health, Inc. moved from a very attractive valuation grade to a risky one. The company appears to be overvalued, given its high P/E ratio of 27 compared to its peer average of 24.25, and a negative price-to-book value of -14.78, indicating significant concerns about its asset valuation. Additionally, the EV to EBITDA ratio stands at 15.20, which is higher than the industry norm, suggesting that the market may be pricing in excessive growth expectations.In comparison to its peers, Cardinal Health's PEG ratio of 0.23 is relatively low, but this is overshadowed by the negative book value and the high EV to Capital Employed ratio of 34.11, which raises red flags about the company's financial health. Over the past year, Cardinal Health has outperformed the S&P 500 with a return of 34.67% compared to 17.14%, but the recent weekly performance shows a decline of 1.59%, contrasting with the S&P's gain of 1.05%. This mixed performance further complicates the valuation outlook for the company.

Q: Is Cardinal Health, Inc. technically bullish or bearish?

As of 24 October 2025, the technical trend for Cardinal Health, Inc. has changed from mildly bullish to bullish. The current stance is bullish with moderate strength, driven by bullish signals from the daily moving averages, Bollinger Bands, and On-Balance Volume (OBV) across both weekly and monthly time frames. However, the MACD and KST indicators show mixed signals, with the weekly MACD being mildly bearish and the Dow Theory indicating a mildly bullish stance on a weekly basis but mildly bearish on a monthly basis. In terms of performance, Cardinal Health has outperformed the S&P 500 significantly, with a year-to-date return of 36.88% compared to the S&P 500's 15.47%, and a one-year return of 44.34% versus 16.90%.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

2.5 M

Shareholding (Sep 2025)

FII

19.62%

Held by 409 FIIs

DII

47.09%

Held by 59 DIIs

Promoter

0.02%

How big is Cardinal Health, Inc.?

22-Jun-2025

As of Jun 24, Cardinal Health, Inc. has a market capitalization of $46.45 billion, with net sales of $222.29 billion and a net profit of $1.56 billion for the latest four quarters. Shareholder's funds are reported at -$3.21 billion, while total assets amount to $45.12 billion.

View full answer

What does Cardinal Health, Inc. do?

22-Jun-2025

Cardinal Health, Inc. is a healthcare services and products company with a market cap of approximately $46.45 billion, reporting net sales of $54.88 billion and a net profit of $508 million for Q1 2025. Key metrics include a P/E ratio of 27.00 and a return on equity of -55.76%.

View full answer

Who are in the management team of Cardinal Health, Inc.?

22-Jun-2025

As of March 2022, Cardinal Health, Inc.'s management team includes CEO Michael Kaufmann and Independent Non-Executive Chairman Gregory Kenny, along with several Independent Directors: Carrie Cox, Calvin Darden, Bruce Downey, and Sheri Edison.

View full answer

Is Cardinal Health, Inc. overvalued or undervalued?

20-Sep-2025

As of May 5, 2022, Cardinal Health, Inc. is considered risky due to its high P/E ratio of 27, negative price-to-book value of -14.78, and elevated EV to EBITDA ratio of 15.20, despite a low PEG ratio of 0.23 and a recent 34.67% return outperforming the S&P 500.

View full answer

Is Cardinal Health, Inc. technically bullish or bearish?

28-Oct-2025

As of October 24, 2025, Cardinal Health, Inc. shows a bullish trend with moderate strength, supported by positive signals from moving averages and OBV, despite mixed MACD and KST indicators, and has significantly outperformed the S&P 500 with a year-to-date return of 36.88%.

View full answer

Compare Cardinal Health, Inc. with Similar Stocks

Cencora, Inc.McKesson Corp.Boston Scientific Corp.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

With a Negative Book Value, the company has a Weak Long Term Fundamental Strength

Flat results in Jun 25

Risky - Negative Book Value

Mojo Parameters

Stock DNA

Industry

Retailing

Market cap

USD 49,531 Million (Mid Cap)

P/E

27.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-1.54

Return on Equity

-64.85%

Price to Book

-17.20

Revenue and Profits:

Net Sales:

64,009 Million

(Quarterly Results - Sep 2025)

Net Profit:

454 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

66.91%

6 Months

71.77%

1 Year

109.28%

2 Years

138.39%

3 Years

286.92%

4 Years

244.69%

5 Years

272.9%

Cardinal Health, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

7.80%

EBIT Growth (5y)

7.59%

EBIT to Interest (avg)

15.03

Debt to EBITDA (avg)

1.01

Net Debt to Equity (avg)

-1.48

Sales to Capital Employed (avg)

94.95

Tax Ratio

26.04%

Dividend Payout Ratio

31.43%

Pledged Shares

Institutional Holding

89.73%

ROCE (avg)

89.43%

ROE (avg)

68.50%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

-14.78

EV to EBIT

20.09

EV to EBITDA

15.20

EV to Capital Employed

34.11

EV to Sales

0.22

PEG Ratio

0.23

Dividend Yield

ROCE (Latest)

169.82%

ROE (Latest)

Negative BV

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Bullish

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Sep 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 169 Schemes (33.26%)

Foreign Institutions

Held by 409 Foreign Institutions (19.62%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 22.44% vs -4.54% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 8.87% vs 6,850.00% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "64,009.00",
          "val2": "52,277.00",
          "chgp": "22.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,004.00",
          "val2": "739.00",
          "chgp": "35.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "80.00",
          "val2": "32.00",
          "chgp": "150.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-101.00",
          "val2": "9.00",
          "chgp": "-1,222.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "454.00",
          "val2": "417.00",
          "chgp": "8.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.00%",
          "val2": "10.70%",
          "chgp": "0.13%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Jun'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Jun 2025 is -1.87% vs 10.66% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Jun 2025 is 83.94% vs 157.70% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "222,575.00",
          "val2": "226,826.00",
          "chgp": "-1.87%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3,263.00",
          "val2": "2,863.00",
          "chgp": "13.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "212.00",
          "val2": "67.00",
          "chgp": "216.42%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-187.00",
          "val2": "-933.00",
          "chgp": "79.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,569.00",
          "val2": "853.00",
          "chgp": "83.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.10%",
          "val2": "9.50%",
          "chgp": "0.16%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY

Sep'25

Sep'24

Change(%)

Net Sales

64,009.00

52,277.00

22.44%

Operating Profit (PBDIT) excl Other Income

1,004.00

739.00

35.86%

Interest

80.00

32.00

150.00%

Exceptional Items

-101.00

9.00

-1,222.22%

Consolidate Net Profit

454.00

417.00

8.87%

Operating Profit Margin (Excl OI)

12.00%

10.70%

0.13%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Sep 2025 is 22.44% vs -4.54% in Sep 2024

Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is 8.87% vs 6,850.00% in Sep 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Jun'25

Jun'25

Jun'24

Change(%)

Net Sales

222,575.00

226,826.00

-1.87%

Operating Profit (PBDIT) excl Other Income

3,263.00

2,863.00

13.97%

Interest

212.00

67.00

216.42%

Exceptional Items

-187.00

-933.00

79.96%

Consolidate Net Profit

1,569.00

853.00

83.94%

Operating Profit Margin (Excl OI)

11.10%

9.50%

0.16%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Jun 2025 is -1.87% vs 10.66% in Jun 2024

Consolidated Net Profit

YoY Growth in year ended Jun 2025 is 83.94% vs 157.70% in Jun 2024

All Annual Results

Company CV

About Cardinal Health, Inc.

Cardinal Health, Inc.

Retailing

Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies. The Medical segment distributes a range of medical, surgical and laboratory products, and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers. This segment also manufactures, sources and develops its own Cardinal Health brand medical and surgical products. It provides post-acute care management and transition services, and software to hospitals.

Company Coordinates

Company Details

7000 Cardinal Pl , DUBLIN OH : 43017-1091

Tel: 1 614 7573033

https://www.cardinalhealth.com/

Registrar Details

Cardinal Health, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

How big is Cardinal Health, Inc.?

Watch in Real-Time

What does Cardinal Health, Inc. do?

Who are in the management team of Cardinal Health, Inc.?

Is Cardinal Health, Inc. overvalued or undervalued?

Is Cardinal Health, Inc. technically bullish or bearish?

Compare Cardinal Health, Inc. with Similar Stocks

MarketsMojo — Loved in India, Now Global

Dashboard

With a Negative Book Value, the company has a Weak Long Term Fundamental Strength

Flat results in Jun 25

Risky - Negative Book Value

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Sep 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY

Annual Results Snapshot (Consolidated) - Jun'25

About Cardinal Health, Inc.

Company Coordinates